Gene alterations in tumor-associated endothelial cells from endometrial cancer

International Journal of Molecular Medicine

Volumn 22, Issue 5, 2008, Pages 619-632

  Du, Xue Lian ^a,b   Jiang, Tao ^b   Zhao, Wen Bo ^a   Wang, Fei ^a   Wang, Gui Li ^a   Cui, Min ^a   Wen, Ze Qing ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

Angiogenesis; Endometrial cancer; Human endometrial endothelial cells; Microarray analyses

Indexed keywords

ACTIN CAPPING PROTEIN GELSOLIN LIKE; ACTIN CAPPING PROTEIN MUSCLE Z ALPHA 1; BLOOD CLOTTING FACTOR 13A1; CATHEPSIN H; CD69 ANTIGEN; COLLAGEN TYPE 3 ALPHA 1; COLLAGEN TYPE 5; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLIN DEPENDENT KINASE INHIBITOR 3; CYCLINE; ENDOSULFINE ALPHA; GELATINASE B; GENE PRODUCT; HEXOKINASE DOMAIN CONTAINING 1; HIGH MOBILITY GROUP B1 PROTEIN; INHIBITOR OF DNA BINDING 4 DOMINANT NEGATIVE HELIX LOOP HELIX PROTEIN; INTERFERON INDUCED PROTEIN WITH TETRATRICOPEPTIDE REPEATS 4; LAMININ BETA 1; LIPOCORTIN 2; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; OSTEOPONTIN; PROTEIN LYSINE 6 OXIDASE; RAS HOMOLOG GENE FAMILY MEMBER C; SOLUBLE 3 BINDING PROTEIN; STROMELYSIN 2; THYMOSIN BETA10; TRANSMEMBRANE PROTEIN 101; UNCLASSIFIED DRUG; VIMENTIN; ZINC FINGER PROTEIN 207;

ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CELL ADHESION; CELL CYCLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENDOMETRIUM CANCER; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; FEMALE; FOCAL ADHESION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC DIFFERENCE; GENETIC IDENTIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MICROARRAY ANALYSIS; MOLECULAR MECHANICS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; UNINDEXED SEQUENCE; UPREGULATION; WESTERN BLOTTING; CANCER INVASION; CELL MOTION; DNA MICROARRAY; ENDOMETRIUM TUMOR; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; TUMOR CELL CULTURE;

CELL MOVEMENT; ENDOMETRIAL NEOPLASMS; ENDOTHELIAL CELLS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TUMOR CELLS, CULTURED;

EID: 59149105272     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm_00000064     Document Type: Article

References (31)

1. Burke C, Foley M, Lenehan P, Kelehan P and Flannelly G: Early stage endometrial carcinoma-a study of management and outcome. Ir Med J 100: 621-623, 2007.
2. Zusterzeel PL, Bekkers RL, Hendriks JC, Neesham DN, Rome RM and Quinn MA: Prognostic factors for recurrence in patients with FIGO stage I and II, intermediate or high risk endometrial cancer. Acta Obstet Gynecol Scand 87: 240-246, 2008.
3. Ayhan A, Taskiran C, Celik C, Yuce K and Kucukali T: The influence of cytoreductive surgery on survival and morbidity in stage IVB endometrial cancer. Int J Gynecol Cancer 12: 448-453, 2002.
4. Sivridis E: Angiogenesis and endometrial cancer. Anticancer Res 21: 4383-4388, 2001.
5. Ozbudak IH, Karaveli S, Simsek T, Erdogan G and Pestereli E: Neoangiogenesis and expression of hypoxia-inducible factor 1alpha, vascular endothelial growth factor, and glucose transporter-1 in endometrioid type endometrium adenocarcinomas. Gynecol Oncol 108: 603-608, 2008.
6. Kamat AA, Merritt WM, Coffey D, et al: Clinical and biological significance of vascular endothelial growth factor in endometrial cancer. Clin Cancer Res 13: 7487-7495, 2007.
7. Morikawa S, Baluk P, Kaidoh T, et al: Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors. Am J Pathol 160: 985-1000, 2002.
8. Baluk P, Morikawa S, Haskell A, Mancuso M and McDonald DM: Abnormalities of basement membrane on blood vessels and endothelial sprouts in tumors. Am J Pathol 163: 1801-1815, 2003.
9. Parker BS, Argani P, Cook BP, et al: Alterations in vascular gene expression in invasive breast carcinoma. Cancer Res 64: 7857-7866. Erratum in: Cancer Res 64: 8794, 2004.
10. St Croix B, Rago C, Velculescu V, et al: Genes expressed in human tumor endothelium. Science 289: 1197-1202, 2000.
11. Madden SL, Cook BP, Nacht M, et al: Vascular gene expression in nonneoplastic and malignant brain. Am J Pathol 165: 601-608, 2004.
12. Lu C, Bonome T, Li Y, Kamat AA, et al: Gene alterations identified by expression profiling in tumor-associated endothelial cells from invasive ovarian carcinoma. Cancer Res 67: 1757-1768, 2007.
13. Sha G, Wu D, Zhang L, et al: Differentially expressed genes in human endometrial endothelial cells derived from eutopic endometrium of patients with endometriosis compared with those from patients without endometriosis. Human Reprod 22: 3159-3169, 2007.
14. Langley RR, Ramirez KM, Tsan RZ, Van Arsdall M, Nilsson MB and Fidler IJ: Tissue-specific microvascular endothelial cell lines from H-2K(b)-tsA58 mice for studies of angiogenesis and metastasis. Cancer Res 63: 2971-2976, 2003.
15. Maxwell GL, Chandramouli GV, Dainty L, Litzi TJ, Berchuck A, Barrett JC and Risinger JI: Microarray analysis of endometrial carcinomas and mixed mullerian tumors reveals distinct gene expression profiles associated with different histologic types of uterine cancer. Clin Cancer Res 11: 4056-4066, 2005.
16. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-ΔΔC(T)) method. Methods 25: 402-408, 2001.
17. Mao X, Cai T, Olyarchuk JG and Wei L: Automated genome annotation and pathway identification using the KEGG Orthology (KO) as a controlled vocabulary. Bioinformatics 21: 3787-3793, 2005.
18. Agrawal D, Chen T, Irby R, et al: Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling. J Natl Cancer Inst 94: 513-521, 2002.
19. Briese J, Schulte HM, Bamberger CM, Löning T and Bamberger AM: Expression pattern of osteopontin in endometrial carcinoma: correlation with expression of the adhesion molecule CEACAM1. Int J Gynecol Pathol 25: 161-169, 2006.
20. Coppola D, Szabo M, Boulware D, Muraca P, Alsarraj M, Chambers AF and Yeatman TJ: Correlation of osteopontin protein expression and pathological stage across a wide variety of tumor histologies. Clin Cancer Res 10: 184-190, 2004.
21. Hirama M, Takahashi F, Takahashi K, et al: Osteopontin overproduced by tumor cells acts as a potent angiogenic factor contributing to tumor growth. Cancer Lett 198: 107-117, 2003.
22. Leali D, Dell'Era P, Stabile H, et al: Osteopontin (Eta-1) and fibroblast growth factor-2 cross-talk in angiogenesis. J Immunol 171: 1085-1093, 2003.
23. Shijubo N, Uede T, Kon S, Nagata M and Abe S: Vascular endothelial growth factor and osteopontin in tumor biology. Crit Rev Oncog 11: 135-146, 2000.
24. Takano S, Tsuboi K, Tomono Y, Mitsui Y and Nose T: Tissue factor, osteopontin, alphavbeta3 integrin expression in microvasculature of gliomas associated with vascular endothelial growth factor expression. Br J Cancer 82: 1967-1973, 2000.
25. Fujita M, Khazenzon NM, Bose S, et al: Overexpression of beta1-chain-containing laminins in capillary basement membranes of human breast cancer and its metastases. Breast Cancer Res 7: 166-167, 2005.
26. Ljubimova JY, Fujita M, Khazenzon NM, Ljubimov AV and Black KL: Changes in laminin isoforms associated with brain tumor invasion and angiogenesis. Front Biosci 11: 81-88, 2006.
27. Karahan N, Gúney M, Baspinar S, Oral B, Kapucuoglu N and Mungan T: Expression of gelatinase (MMP-2 and MMP-9) and cyclooxygenase-2 (COX-2) in endometrial carcinoma. Eur J Gynaecol Oncol 28: 184-188, 2007.
28. Riddick AC, Shukla CJ, Pennington CJ, et al: Identification of degradome components associated with prostate cancer progression by expression analysis of human prostatic tissues. Br J Cancer 92: 2171-2180, 2005.
29. Aung PP, Oue N, Mitani Y, et al: Systematic search for gastric cancer-specific genes based on SAGE data: melanoma inhibitory activity and matrix metalloproteinase-10 are novel prognostic factors in patients with gastric cancer. Oncogene 25: 2546-2557, 2006.
30. Van Themsche C, Alain T, Kossakowska AE, Urbanski S, Potworowski EF and St-Pierre Y: Stromelysin-2 (matrix metalloproteinase 10) is inducible in lymphoma cells and accelerates the growth of lymphoid tumors in vivo. J Immunol 173: 3605-3611, 2004.
31. Lin TS, Chiou SH, Wang LS, et al: Expression spectra of matrix metalloproteinases in metastatic non-small cell lung cancer. Oncol Rep 12: 717-723, 2004.